Home › NDC Lookup › Ingredients › Benzalkonium Chloride › 83823-0002-01
🧴image loading
(from DailyMed)

NOxyDERM Benzalkonium Chloride .038 g/29.5mL Liquid, 29.5 mL — NDC 83823-002-01 (Billing 83823-0002-01)

by NOxy Health Products · 29.5 mL in 1 BOTTLE, PUMP

This is a package of 29.5 mL of NOxyDERM Benzalkonium Chloride .038 g/29.5mL Liquid from NOxy Health Products, marketed since Sep 2024 and currently FDA-listed. It is this product's only package size.

NDC 83823-0002-01
🏷️ FDA NDC (as labeled) 83823-002-01 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 83823-002-01 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
83823 labeler · 002 product · 01 package
Package marketed since
Sep 30, 2024
Sample package
No — commercial package
Listing certified through
Dec 31, 2027
Barcode (UPC-A, from the NDC)
3 8382300201 8
FDA record last changed
Jul 24, 2026
⚠️
Other active recalls for Benzalkonium Chloride (different manufacturers) — 6 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Apr 8, 2026 — CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated (Blaine Labs Inc) · FDA recall D-0693-2026
Class II · Apr 8, 2026 — CGMP Deviations; product manufactured in the same facility under the same conditions as the product found to be contaminated (Blaine Labs Inc) · FDA recall D-0699-2026
Class II · Jan 20, 2026 — CGMP Deviations (ACME UNITED CORPORATION) · FDA recall D-0375-2026
Class II · Jan 20, 2026 — CGMP Deviations (ACME UNITED CORPORATION) · FDA recall D-0369-2026
Class II · Jan 20, 2026 — CGMP Deviations (ACME UNITED CORPORATION) · FDA recall D-0365-2026
Class II · Jan 20, 2026 — CGMP Deviations (ACME UNITED CORPORATION) · FDA recall D-0374-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 83823-002-01
Product NDC 83823-002
11-digit billing NDC 83823000201
RxCUI 1020365
UNII F5UM2KM3W7
Application # M003
SPL Set ID 1e2cb45c-7e70-01dd-e063-6294a90aa16b
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-09-30
Route TOPICAL
Dosage form LIQUID
Substance BENZALKONIUM CHLORIDE
Quick answers
  • RxCUI (RxNorm): 1020365
Why two NDCs? The FDA registers this code as 83823-002-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 83823-0002-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Quaternary ammonium compounds class.

Drug family (ATC) Quaternary ammonium compounds, Medicated dressings with antiinfectives, Antiseptics
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

NOxyDERM Benzalkonium Chloride is a topical liquid product containing benzalkonium chloride, an antimicrobial agent. This over-the-counter product is marketed under FDA's monograph rules for antiseptic and antimicrobial skin preparations. Benzalkonium chloride is commonly used in topical products to help reduce bacteria on the skin surface. This product is intended for topical application only.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
83823-0002-01 You're viewing this Main listing 29.5 mL in 1 BOTTLE, PUMP 2024-09-30 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Instant Foam Non-alcohol PURE Hand Sanitizer .13 g/100mL 11084-0300-01 SC 47 ml — — Discontinued —
Foaming Hand 1.3 mg/mL 11344-0224-04 Nice-Pak 750 ml — — Discontinued —
Benzalkonium chloride 1.3 mg/mL 11673-0681-23 Target 68 ml — — FDA listed —
QS Plus Instant Hand Sanitizer 1.3 mg/mL 13302-0457-10 Romaine 1000 ml — — Discontinued —
X3 Clean 1.3 mg/mL 26550-0001-12 X3 75 ml — — FDA listed —
Tork Hand Sanitizer Alcohol Free Foam .13 g/100mL 49351-0103-01 Essity 6 bottles — — FDA listed —
Tork Hand Sanitizing Alcohol-Free Foam 1.3 mg/mL 49351-0303-01 Essity 1000 ml — — FDA listed —
X3 Clean Foaming Hand Sanitizer 1.3 mg/mL 49354-0055-75 HK 75 ml — — FDA listed —
Ben E. Keith FIHS 1.3 mg/mL 50980-0207-12 Ben 1000 ml — — FDA listed —
American Red Cross Antiseptic Cleansing Foam .13 g/100mL 51628-4539-01 MY 177 ml — — FDA listed —
North Woods Derma Foam Hand Sanitizer 1.3 mg/mL 53125-0700-54 Superior 1000 ml — — Discontinued —
DermaCen Non-Alcohol Foaming Hand Sanitizer .13 g/100mL 62654-0141-14 Central 532 ml — — FDA listed —
Byotrol Hand Sanitizer 1.3 mg/mL 63002-0002-12 Advanced 1250 ml — — FDA listed —
Hand Sanitizer 1.3 g/mL 63002-0004-33 Advanced 9.76 ml — — FDA listed —
99 Plus Hand Sanitizer 1.3 mg/mL 63533-0457-10 Momar 1000 ml — — FDA listed —
Lite nFoamy Eucalyptus Mint Sanitizing Handwash 1.3 g/L 64009-0332-72 Spartan 532 l — — FDA listed —
Lite nFoamy E2 Sanitizing Handwash 1.3 g/L 64009-0333-95 Spartan 3.79 l — — FDA listed —
Enriched Foam Alcohol-Free Hand Sanitizer 13 mg/100mL 65321-0039-01 Rubbermaid 4 pouches — — FDA listed —
Alcohol Free Foaming Hand Sanitizer 1.3 mg/mL 65601-0700-04 Betco 3780 ml — — FDA listed —
Band Aid Antiseptic Cleansing 1.3 mg/mL 69968-0728-01 Kenvue 68 ml — — FDA listed —
Blue Green Foam .13 g/100mL 70411-0100-07 H2Ocean, 207 ml — — FDA listed —
ElimiShield Hunt Core Body Foam for Hunters 1.3 mg/mL 71853-0010-00 Bryson 200 ml — — FDA listed —
Germ Free 24 Hand Sanitizer 1.3 mg/mL 71884-0006-01 Enviro 50 ml — — FDA listed —
Doctor Inks Hand Sanitizer 1.3 mg/mL 71884-0201-01 Enviro 58 ml — — FDA listed —
Mountain Air Scent FOAMING HAND SANITIZER 1.3 mg/mL 74177-0040-08 K7 236 ml — — FDA listed —
Pine and Honey Scent FOAMING HAND SANITIZER 1.3 mg/mL 74177-0041-08 K7 236 ml — — FDA listed —
Simply Lavender Scent FOAMING HAND SANITIZER 1.3 mg/mL 74177-0042-08 K7 236 ml — — FDA listed —
Vanilla Coconut Scent FOAMING HAND SANITIZER 1.3 mg/mL 74177-0043-16 K7 473 ml — — FDA listed —
Foaming Hand Sanitizer 1.3 g/1000mL 75044-0280-16 American 2 bottles — — FDA listed —
American Red Cross Antiseptic Cleansing Foam .13 g/100mL 75742-0082-01 Zhejiang 177 ml — — FDA listed —
Hand Sanitizer .13 g/100mL 76370-0006-05 Tazza 1000 ml — — Discontinued —
Gentlecare Hand And Skin Sanitizer 1.3 mg/mL 78181-0020-02 PARAGON 50 ml — — FDA listed —
KleenLine Essentials Alcohol Free Foaming Hand Sanitizer 1.3 mg/mL 79258-0700-29 Brady 1000 ml — — FDA listed —
Hygiene Clean Balsam Fir Hand Sanitizer Alcohol Free 1.3 mg/mL 80499-0004-01 USA 237 ml — — FDA listed —
Hygiene Clean Leather Oak Hand Sanitizer Alcohol Free 1.3 mg/mL 80499-0005-01 USA 237 ml — — FDA listed —
Hygiene Clean Mahogany Teakwood Hand Sanitizer Alcohol Free 1.3 mg/mL 80499-0006-01 USA 237 ml — — FDA listed —
Hygiene Clean Pumpkin Spice Hand Sanitizer Alcohol Free 1.3 mg/mL 80499-0007-01 USA 237 ml — — FDA listed —
Hygiene Clean Spring Bloom Hand Sanitizer Bottle Alcohol Free 1.3 mg/mL 80499-0025-08 USA 237 ml — — FDA listed —
Hygiene Clean Lilac Garden Hand Sanitizer Bottle Alcohol Free 1.3 mg/mL 80499-0026-08 USA 237 ml — — FDA listed —
Hygiene Clean Lavender Blossom Hand Sanitizer Bottle Alcohol Free 1.3 mg/mL 80499-0027-08 USA 237 ml — — FDA listed —
Hygiene Clean Clean Cotton Hand Sanitizer 1.3 mg/mL 80499-0100-01 USA 800 ml — — FDA listed —
Hygiene Clean Eucalyptus Hand Sanitizer 1.3 mg/mL 80499-0101-01 USA 800 ml — — FDA listed —
Hygiene Clean Luxury Clean Hand Sanitizer 1.3 mg/mL 80499-0102-01 USA 800 ml — — FDA listed —
Antiseptic Foaming Hand Sanitizer 1.3 mg/mL 82442-0812-20 Target 2 bottles — — FDA listed —
NOxyDERM .13 g/100mL 83823-0001-01 NOxy 100 ml — — FDA listed —
NOxyDERM .038 g/29.5mLthis 83823-0002-01 NOxy 29.5 ml — — FDA listed —
Foaming Hand Sanitizer 1.3 mg/mL 83986-0118-45 UpLift 1150 ml — — FDA listed —
Guardelle .13 g/100mL 85754-0000-02 Social 52 ml — — FDA listed —
GrowDefender Antibacterial Foam 1.3 mg/mL 87109-0013-01 Grow 50.68 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Sep 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII XF417D3PSL
    Anhydrous citric acid is a sour, crystalline powder derived from citric acid with water removed. In medicines, it acts as a buffer to control pH, adds tartness to improve taste, and helps tablets disintegrate.
  • UNII 03DH2IZ3FY
    A mild cleansing agent derived from coconut oil. It's used in medicines as a surfactant to help dissolve or distribute other ingredients evenly throughout the formulation.
  • UNII M0KG633D4F
    Sodium nitrite is an inorganic salt used as a preservative and anti-caking agent in medications. It helps prevent bacterial growth and keeps powdered or granular formulations from clumping during storage.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

4 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesSodium Nitrite CoCo Betaine Deionized Water Citric Acid

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerNOxy Health Products
FDA applicationM003 (OTC MONOGRAPH DRUG)
Labeler code83823
First marketedSep 2024
Product typeHuman Otc Drug
Portfolio2 products on file

More NDCs from NOxy Health Products labeler code 83823

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📖 Instructions for Use 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 32 words ▾

Indications and usage Directions: Clean the affected area Apply a small amount of this product on the area once daily May be covered with a sterile bandage If bandaged, let dry first

⏱️ Dosage and Administration 13 words ▾

Dosage Apply a small amount of this product on the area once daily

⚠️ Warnings 6 words ▾

Warnings Warnings: For external use only

🧪 Active Ingredient 11 words ▾

Active Ingredient Active Ingredient Purpose Benzalkonium Chloride 0.13% First Aid Antiseptic

🧪 Inactive Ingredients 10 words ▾

Inactive ingredients Sodium Nitrite CoCo Betaine Deionized Water Citric Acid

🎯 Purpose 17 words ▾

Purpose Purpose First aid antiseptic Uses: first aid to help prevent infection in minor: cuts scrapes burns

📄 Do Not Use 41 words ▾

Do not use Do not use in the eyes over large areas of the body longer than 1 week unless directed by a doctor Ask a doctor before use if you have deep or puncture wounds, animal bites, or serious burns

📄 When Using This Product 6 words ▾

Warnings Warnings For external use only

📄 Keep Out of Reach of Children 23 words ▾

Keep out of reach of children Keep out of reach of children. If swallowed, get medical help or contact Poison Control right away

📄 Other Information 7 words ▾

Other safety information Store at room temperature

📄 Questions or Comments 4 words ▾

Questions Questions? call 1-888-585-4120

📖 Instructions for Use 32 words ▾

Instructions for use Directions Clean the affected area Apply a small amount of this product on the area once daily May be covered with a sterile bandage If bandaged, let dry first

📄 Package Label / Principal Display Panel 10 words ▾

NOxyDERM 1.0fl oz Label NDC83823-002-01 Front Label NDC83823-002-01 Back Label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for NOxyDERM (this brand).

Top reported reactions

Drug Hypersensitivity118
Condition Aggravated114
Arthralgia112
Musculoskeletal Stiffness111
Pain In Extremity111
Infection110
Hepatotoxicity108

Age at onset

Infant1
Adolescent3
Adult36
Elderly10

Reporter sex

331 reports
Male · 28%
Female · 72%
Unknown · 0%
Reports over time (by year) — tap or hover for the count & year
2020 2022 2024 2026 77 5
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by NOxy Health Products. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
NOxy Health Products is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 83823-0001-01 · NOxy 83827-1208-02 · Donis →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.